Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025)
Benitec Biopharma (BNTC) posted Other Non-Current Assets of $11000.0 for Q4 2025, down 97.8% sequentially from $500000.0 in Q3 2025, and down 56.0% YoY from $25000.0 in Q4 2024.
Benitec Biopharma (BNTC) Other Non-Current Assets (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Other Non-Current Assets for 7 years, with the latest figure at $11000.0 in Q4 2025.
- Quarterly Other Non-Current Assets fell 56.0% year-over-year to $11000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11000.0 (down 56.0% YoY) and the FY2025 annual result came in at $28000.0, up 12.0% from the prior year.
- Other Non-Current Assets declined to $11000.0 in Q4 2025 per BNTC's latest filing, from $500000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $984000.0 in Q2 2021 and troughed at $9000.0 in Q1 2021.
- A 5-year average of $188052.6 and a median of $97000.0 in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets soared 10833.33% in 2021, then sank 86.28% in 2022.
- Over 5 years, Other Non-Current Assets stood at $161000.0 in 2021, then retreated by 27.95% to $116000.0 in 2022, then sank by 30.17% to $81000.0 in 2023, then tumbled by 69.14% to $25000.0 in 2024, then tumbled by 56.0% to $11000.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $11000.0, $500000.0, and $28000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 500,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Dec 31, 2023 | 81,000.00 |
| Sep 30, 2023 | 85,000.00 |
| Jun 30, 2023 | 97,000.00 |
| Mar 31, 2023 | 105,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 135,000.00 |
| Mar 31, 2022 | 156,000.00 |
| Dec 31, 2021 | 161,000.00 |
| Sep 30, 2021 | 811,000.00 |
| Jun 30, 2021 | 984,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 562,000.00 |